EDITAS MEDICINE INC.
3.1700
07-November-24 15:59:58
15 minutes delayed
Stocks
-0.1100
-3.35%
Today's range
3.1100 - 3.3000
ISIN
N/A
Source
NASDAQ
-
Editas Medicine Announces Fourth Quarter and Full Year 2020 Results and Update
25 Feb 2021 07:00:03 By Nasdaq GlobeNewswire
-
18 Feb 2021 16:02:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Appointment of James C. Mullen as Chief Executive Officer
08 Feb 2021 08:00:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Pricing of Offering of Common Stock
20 Jan 2021 22:30:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Offering of Common Stock
19 Jan 2021 16:01:00 By Nasdaq GlobeNewswire
-
Editas Medicine Reports on Recent Progress and Outlook at J.P. Morgan Healthcare Conference
11 Jan 2021 06:05:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces the FDA has Cleared Initiation of the EDIT-301 Clinical Trial
11 Jan 2021 06:02:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Transition of Chief Scientific Officer
11 Jan 2021 06:00:00 By Nasdaq GlobeNewswire
-
Editas Medicine to Present at the 39th Annual J.P. Morgan Healthcare Conference
04 Jan 2021 16:05:00 By Nasdaq GlobeNewswire